Concord Biotech (CONCORDBIO.NS) Stock Price
Concord Biotech Price
Revenue has compounded at 12.8% per year over the past 6 years to 10.55 B INR. Earnings per share have grown at 7.5% per year over the last 6 years. Concord Biotech's net margin stands at 24.7%, broadly stable from 24.5% several years earlier. Concord Biotech currently offers a dividend yield of about 0.79%. The payout ratio is around 30% of earnings. The dividend has grown at 10.6% per year over the past 2 years. Analysts set a median price target of 1,443.30 INR, implying 6.6% above the current price. Of 10 analysts, 8 rate the stock a buy — an overall Buy consensus.
Concord Biotech stock price
Concord Biotech business model & stock analysis
Frequently asked questions about Concord Biotech
Analysts currently set an average price target of 1,448.40 INR for the Concord Biotech stock (median: 1,443.30 INR), implying +6.9 % versus the latest price. The consensus is based on 10 analyst ratings.
10 analysts currently rate the Concord Biotech stock: 7 recommend buying, 3 holding and 0 selling.
Converted at the current exchange rate, the Concord Biotech share trades at 12.49 EUR (1,354.40 INR).
The revenue of Concord Biotech is 10.55 B INR. This figure is based on current financial data and reflects the company's business performance.
The profit of Concord Biotech is 2.61 B INR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Concord Biotech is currently 54.31. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Concord Biotech stock.
The price-to-sales ratio (P/S) of Concord Biotech is currently 13.43. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Concord Biotech stock.
The Eulerpool Quality Score for Concord Biotech is 4/10.
The ISIN of Concord Biotech is INE338H01029. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Concord Biotech is CONCORDBIO.NS. The ticker symbol is used to trade Concord Biotech shares on the stock exchange.
Concord Biotech stock
Concord Biotech Peer Group
Concord Biotech Ticker
Concord Biotech FIGI
All fundamentals and in-depth analysis of Concord Biotech
Our stock analysis for Concord Biotech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Concord Biotech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.